Nuvasive reported $214.41M in Gross Profit on Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Abbott ABT:US USD 5.5B 283M
Atricure ATRC:US USD 61.71M 1.81M
Baxter International BAX:US USD 1.15B 310M
Becton, Dickinson and BDX:US USD 2.13B 56M
Boston Scientific BSX:US USD 2.22B 18M
Cardiovascular Systems CSII:US USD 42.98M 3.25M
Cooper Companies COO:US USD 544.2M 7.9M
Dexcom DXCM:US USD 494.2M 44.7M
Edwards Lifesciences EW:US USD 1.09B 23.6M
Globus Medical GMED:US USD 188.65M 6.53M
Haemonetics HAE:US USD 157.91M 15.85M
Hologic HOLX:US USD 617.9M 95M
Insulet PODD:US USD 188.3M 2M
Integra Lifesciences IART:US USD 240.94M 13.6M
Intuitive Surgical ISRG:US USD 1.11B 58.8M
Johnson & Johnson JNJ:US USD 15.94B 56M
Medtronic MDT:US USD 5.1B 229M
Merit Medical Systems MMSI:US USD 128.57M 6.49M
Nuvasive NUVA:US USD 214.41M 10.28M
Stryker SYK:US USD 3.26B 461M
Tandem Diabetes Care TNDM:US USD 104.42M 2.48M
Teleflex TFX:US USD 373.96M 14.88M
Zimmer Biomet Holdings Inc ZBH:US USD 1.3B 123.2M